MacroGenics | MGNX - Ebit





Ebit Perubahan Tanggal
AbbVie USD 6.88B 156M 2026-09
Amgen USD 4.68B 65M 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Genmab DKK 407M 221M 2026-06
Geron USD 5.73M 15.26M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
J&J USD 6.47B 1B 2026-09
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -65.25M 33.36M 2026-06
Merck USD 7.33B 6.49B 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Xencor USD -36.6M 41.26M 2026-06